Select transformants on LB plates containing 100 μg/ml ampicillin  Successful colonies K562: 27 colonies Hela: 11 colonies IM9: 25 colonies Lab Meeting.

Slides:



Advertisements
Similar presentations
Subcloning Techniques
Advertisements

Bacteria Transformation!
Bacterial Transformation. Broad and Long Term Objective To characterize a single clone from an Emiliania huxleyi cDNA library using sequence analysis.
Transformation of Escherichia coli
Bacterial Transformation. Broad and Long Term Objective To characterize a single clone from an Emiliania huxleyi cDNA library using sequence analysis.
Bacterial Transformation RET Summer Overall Picture Bio-Rad pGLO Transformation Insertion of GFP gene into HB101 E. coli.
2nd lab competent cells formation and transformation of competent cells with DNA. BCH 462 [practical]
Competent cells formation and transformation of competent cells with DNA. BCH 462 [practical] 2 nd lab.
Lab Exam 2 Overview. Bacterial Transformation To impart new phenotype by adding expressible genes Why use bacteria? – Rapid growth – Plasmids as vectors.
GFP Transformation Lab Images taken without permission from
Chapter 9 – DNA-Based Information Technologies
Cat # SL Store at 4 0 C LipoJet DNA In Vitro Transfection Reagent A Protocol for Transfections of Mammalian Cell 100 l 500 l 1000 l
Lab meeting Plasmid preparation and Linearize the pcDNA3.1 vector  pcDNA3.1 digest with ScaI- blunt end  Plasmid preparation using Midi kit.
Lab meeting  1 st Plasmid preparation of K562, Hela, IM9 -Midi Kit Quiagen  2 nd Prepare control sample within the plasmid preparation process.
1 Expression of Metabotropic Glutamate Receptors.
Transfection.
Lab meeting Dilute [pcDNA3.1+cDNA U2AF1] up to 20µl (1µg/µl) Linearize pcDNA3.1+cDNA U2AF1 by ScaI ScaI1µl 10X NEB buffer (No.3)5µl BSA2µl.
19.1 Techniques of Molecular Genetics Have Revolutionized Biology
Cat # SL Store at 4 0 C SL SuperFection™ DNA Transfection Reagent Small 0.5 ml Large 1.0 ml Gaither Drive Gaithersburg, MD FAX.
Confirmation of positive clones Screening of positive clones Selection of high copy number clones Selection of positive clones FLUTCORE vaccine yeast constructs.
▶ Objective : To know methods that make new cell line through stable transfection 김준섭.
Cat # SL Store at 4 0 C LipoD293 DNA In Vitro Transfection Reagent (Ver. II) 100  l 500  l 1000  l Gaither Drive Gaithersburg, MD
Cat # SL Store at 4 0 C GenJet™ siRNA Transfection Reagent Small 0.5 ml Large 1.0 ml Gaither Drive Gaithersburg, MD FAX
Genetic Transformation of Bacteria and Gene Regulation.
Products > B16-F10 Transfection Reagent (Mouse Melanoma Cells) Altogen Biosystems offers the B16-F10 Transfection Reagent among a host of 100+ cell line.
Transformation MISS : SALSABEEL H. AL- JOUJOU.
Products > 293T/17 Transfection Reagent (Embryonic Kidney Cells, CRL-11268) Altogen Biosystems offers the 293T/17 Transfection Reagent among a host of.
Lab meeting Nguyen Thi Dai Trang. Electroporation of K562, Hela, IM9  Protocol 1. 2x10 6 cells 2. PBS wash 2 times 3. Suspend in 90µl PBS.
Products > Transfection Reagent for BMS/BMS2 Cells (Bone Marrow Cells) Altogen Biosystems offers the BMS2 Transfection Reagent among a host of 100+ cell.
DNA Transformation Lab E Coli with PCU. Avery–MacLeod–McCarty experiment Showed DNA is the substance that causes bacterial transformation.
Products > HEK-293 Transfection Reagent (Epithelial Kidney Cells) Altogen Biosystems offers the HEK-293 Transfection Reagent among a host of 100+ cell.
Products > HeLa-S3 Transfection Reagent (Cervical Adenocarcinoma) Altogen Biosystems offers the HeLa-S3 Transfection Reagent among a host of 100+ cell.
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Lab# 2 Competent Cells Formation and Transformation of Competent Cells with plasmid DNA. BCH 462 [practical]
Transformation of Bacteria
Products > T98G Transfection Reagent (Glioblastoma Cells, CRL-1690)
Transformation of Escherichia coli
Products > L6 Transfection Reagent (Myeloma Cells, CRL-1458)
Products > CFPEo (HTRpC) Transfection Reagent (Trachea Epithelium)
Products > 4T1 Transfection Reagent (Breast Cancer Cells, CRL-2539)
Products > CHO Transfection Reagent (Chinese Hamster Ovary Cells)
Products > BT-20 Transfection Reagent (Breast Carcinoma Cells)
Products > CT26.WT Transfection Reagent (Colon Carcinoma)
Products > AsPC-1 Transfection Reagent (Pancreatic Beta Cells)
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Protocol for Generation of Stable Cell LinesStable Cell Lines.
Products > Keratinocyte Transfection Reagent (Keratinocytes)
Genetic Transformation of Bacteria and Gene Regulation
Presentation Topic Cloning Vector and its Types Presented By
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Products > KB Transfection Reagent (Mouth Epidermal Carcinoma)
Products > HeLa Transfection Reagent (Cervix Adenocarcinoma Cells)
Products > Hepa 1-6 Transfection Reagent (Hepatoma Cells)
Functional Analysis of Genes
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Products > NCI-H441 Transfection Reagent (Lung Adenocarcinoma)
Transformation of Escherichia coli
Gangliosides GD1b, GT1b, and GQ1b Suppress the Growth of Human Melanoma by Inhibiting Interleukin-8 Production: the Inhibition of Adenylate Cyclase1 
Products > NCI-H358 Transfection Reagent (Bronchioalveolar Cells)
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Products > NCI-H23 Transfection Reagent (Lung Adenocarcinoma)
Products > HCT-116 Transfection Reagent (Colon Carcinoma)
Products > ASMC Transfection Reagent (Aortic Smooth Muscle Cells)
Products > NCI-H292 Transfection Reagent (Lung Carcinoma, CRL1848)
HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells  Mei Chung.
Products > CLBPEC Transfection Reagent (Neuroblastoma Cells)
The Pro162 Variant is a Loss-of-Function Mutation of the Human Melanocortin 1 Receptor Gene  Celia Jiménez-Cervantes, Concepción Olivares, Petra González,
Transformation of Escherichia coli
A. A. XPCKD and KIN17KD HeLa cells grow poorly 2 weeks after transfection. Forty-eight hours after transfection, cells were plated at the same density.
Presentation transcript:

Select transformants on LB plates containing 100 μg/ml ampicillin  Successful colonies K562: 27 colonies Hela: 11 colonies IM9: 25 colonies Lab Meeting

Sequencing  pcDNA3.1 + cDNA was sequenced in both forward and reverse direction  confirm Forward Reverse  Successful colonies K562: 2/27 (No.1, 4) Hela: 3/11 (No.2, 3, 11) IM9: 4/25 (No.1, 2, 5, 13) No mutation Full length sequence was cloned Proper orientation

Analyze transformants for the presence of insert K562HelaIM9 5000bp 500bp pcDNA3.1 : 5428 bp Cloned cDNA U2AF1 : 552 bp

Next step

Determining antibiotic sensitivities  Protocol: 1. Plate or split a confluent plate so the cells will be approximately 25% confluent. Prepare a set of 6–7 plates. Add the following concentrations of antibiotic to each plate: – For Geneticin® selection, test 0, 50, 125, 250, 500, 750, and 1000 μg/ml Geneticin®. 2. Replenish the selective media every 3–4 days, and observe the percentage of surviving cells. 3. Count the number of viable cells at regular intervals to determine the appropriate concentration of antibiotic that prevents growth within 1–3 weeks after addition of the antibiotic.  Once the appropriate Geneticin concentration to use for selection in host cell line was detected  possible to generate a stable cell line expressing gene of interest. Source:  Determine the minimum concentration of Neomycin required to kill untransfected host cell line (K562, Hela, IM9)  Test a range of concentrations to determine the minimum concentration necessary for cell line.

Set up protocol for determine Neomycin sensitivities of Hela 50 μg/ml 125 μg/ ml 125 μg/ ml 250 μg/ ml 500 μg/ ml 750 μg/ml 1000 μg/m l Control  split a confluent plate so the cells will be approximately 25% confluent  Neomycin 10mg/ml  A1-3 : 500 μg/ml cells + 0 μg/ml Neo μg/ml RPMI 10% FBS P.S  A4-6 : 500 μg/ml cells + 5 μg/ml Neo μg/ml RPMI 10% FBS P.S  B1-3 : 500 μg/ml cells + 12,5 μg/ml Neo + 487,5 μg/ml RPMI 10% FBS P.S  B4-6 : 500 μg/ml cells + 25 μg/ml Neo μg/ml RPMI 10% FBS P.S  C1-3 : 500 μg/ml cells + 50 μg/ml Neo μg/ml RPMI 10% FBS P.S  C4-6 : 500 μg/ml cells + 75 μg/ml Neo μg/ml RPMI 10% FBS P.S  D4-6 : 500 μg/ml cells μg/ml Neo μg/ml RPMI 10% FBS P.S  Total volume of Hela cells + selective medium : 1 mL  Replenish the selective media every 3–4 days, and observe the percentage of surviving cells.  Count the number of viable cells at regular intervals to determine the appropriate concentration of antibiotic that prevents growth within 1–3 weeks after addition of the antibiotic.

To create stable cell line  Linearize the pcDNA™3.1(+) vector Linearize the pcDNA3.1 + cDNA U2AF1 Source:

Electroporation

Selection of stable integrant  Once the appropriate Geneticin concentration to use for selection in host cell line was detected  possible to generate a stable cell line expressing gene of interest hours after transfection, wash the cells and add fresh medium to the cells hours after transfection, split the cells into fresh medium containing Neomycin at the predetermined concentration required for cell line. Split the cells such that they are no more than 25% confluent. 3. Feed the cells with selective medium every 3–4 days until Geneticin-resistant foci can be identified. 4. Pick and expand colonies in 96- or 48-well plates.